{"filing":{"accession_number":"0000856982-26-000042","cik":"0000856982","ticker":"MMSI","company_name":"MERIT MEDICAL SYSTEMS INC","form":"8-K","filing_date":"2026-07-30","report_date":"2026-07-30","primary_document":"mmsi-20260730x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698226000042/mmsi-20260730x8k.htm"},"events":[{"id":22532,"run_id":20386,"accession_number":"0000856982-26-000042","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Merit Medical Systems issued a press release on July 30, 2026 announcing Q2 2026 operating and financial results, including revenue of $418.8 million (up 10%), GAAP EPS of $0.65 (up 20%), and updated full-year 2026 guidance.","company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","filing_date":"2026-07-30","form":"8-K","submitted_at":null,"items":[{"id":22503,"accession_number":"0000856982-26-000042","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Merit Medical Systems issued a press release on July 30, 2026 announcing its operating and financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $418.8 million (up 10%), GAAP EPS of $0.65 (up 20%), and updated full-year 2026 guidance. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:17:20.082745+00:00","company_name":"","ticker":null,"filing_date":""},{"id":22504,"accession_number":"0000856982-26-000042","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Merit Medical disclosed its Q2 2026 operating and financial results on July 30, 2026, including reported revenue of $418.8 million (up 10%), GAAP EPS of $0.65 (up 20%), and updated full-year 2026 guidance. The press release (Exhibit 99.1) contains comprehensive financial statements, revenue breakdowns by product category, and forward guidance. This is a standard quarterly earnings release, material to investors assessing the company's financial performance and trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:17:20.082745+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22503,"accession_number":"0000856982-26-000042","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Merit Medical Systems issued a press release on July 30, 2026 announcing its operating and financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $418.8 million (up 10%), GAAP EPS of $0.65 (up 20%), and updated full-year 2026 guidance. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:17:20.082745+00:00","company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","filing_date":"2026-07-30"},{"id":22504,"accession_number":"0000856982-26-000042","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Merit Medical disclosed its Q2 2026 operating and financial results on July 30, 2026, including reported revenue of $418.8 million (up 10%), GAAP EPS of $0.65 (up 20%), and updated full-year 2026 guidance. The press release (Exhibit 99.1) contains comprehensive financial statements, revenue breakdowns by product category, and forward guidance. This is a standard quarterly earnings release, material to investors assessing the company's financial performance and trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:17:20.082745+00:00","company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","filing_date":"2026-07-30"}]}